海外マルファン情報

米国マルファン症候群患者団体The Marfan Foundationからの情報を中心に、マルファン症候群や関連疾患についての海外情報を翻訳して発信します。

ACE阻害薬およびARBとCOVID-19について


The Marfan Foundation and Loeys-Dietz Syndrome Foundation Join Forces

 

34:03-35:58

 

Q:
Now we're gonna jump over to Hal and Bart for the medical question.
I'm really into you COVID-19. Vincent says it looks like COVID-19 is also vascular virus in addition to respiratory and that ACE inhibitors can actually aid in prevention. Does that mean Loeys-Dietz patients on Losartan are actually better off than others? He just says it might be nice to have some benefit to having Loeys-Dietz of being on Losartan?

ロイス・ディーツ症候群患者はロサルタンを飲むことで、COVID-19の経過はよくなるのでしょうか?

 

A:
Yeah, so um, it's an excellent question. It's known that both ACE inhibitors and medications like Losartan and called angiotensin receptor blockers can increase the amount of a protein in the body called ACE2. There was some concern that higher levels of ACE2 might make people more prone to COVID-19 infection, but that clearly is not the case. That question, I think, has now been asked and answered.

ACE阻害薬やARB(ロサルタン)は共に、体内でACE2と呼ばれるタンパク質の量を増加させることが知られています。ACE2が増えすぎると、COVID-19に罹患しやすくなるという懸念がありましたが、そのようなことはありません。それについては、以前のセミナーでお話しました。

 

There is some speculation that medications such as ACE inhibitors or
angiotensin receptor blockers may be protective in some way. Early data that are coming out are suggesting that that is true for ACE inhibitors.

COVID-19に対し、ACE阻害薬やARBが何らかの保護効果があるという憶測があり、ACE阻害薬については、以前のデータから保護効果があることが予想されます。

 

We don't yet have a clear answer with regard to angiotensin receptor blockers but at a minimum people can feel confident that the medications that they're taking for Loeys-Dietz syndrome or Marfan syndrome are not making them more vulnerable in any way. If anything, there may be a protective effect but it's still early days in understanding that.

ARBについては明確な答えは出ていませんが、少なくとも、ロイス・ディーツ症候群やマルファン症候群で使われる薬のせいで、COVID-19に罹患しやすくなるということはないのでご安心ください。ひょっとしたら、保護的な効果があるかもしれませんが、まだ結論は出ていません。

 

The Marfan Foundation did not participate in the translation of these materials and does not in any way endorse them. If you are interested in this topic, please refer to our website, Marfan.org, for materials approved by our Professional Advisory Board.

The Marfan Foundation は、当翻訳には関与しておらず、翻訳内容に関してはいかなる承認も行っておりません。このトピックに興味をお持ちの方は、Marfan.org にアクセスし、当協会の専門家から成る諮問委員会が承認した内容をご参照ください。